Tolerability and effects on quality of life of twice-daily extended-release carbamazepine in adults with seizure disorders: An open-label, 12- to 36-month continuation study

Author: Edward Hogan R.   Garnett W.R.   Thadani V.M.   Carbatrol Study Group  

Publisher: Elsevier

ISSN: 0149-2918

Source: Clinical Therapeutics, Vol.25, Iss.10, 2003-10, pp. : 2586-2596

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content